These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 32068112)

  • 1. Potential frameworks to support evaluation of mechanistic data for developmental neurotoxicity outcomes: A symposium report.
    Carlson LM; Champagne FA; Cory-Slechta DA; Dishaw L; Faustman E; Mundy W; Segal D; Sobin C; Starkey C; Taylor M; Makris SL; Kraft A
    Neurotoxicol Teratol; 2020; 78():106865. PubMed ID: 32068112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations for harmonization of data collection and analysis of developmental neurotoxicity endpoints in regulatory guideline studies: Proceedings of workshops presented at Society of Toxicology and joint Teratology Society and Neurobehavioral Teratology Society meetings.
    Li AA; Sheets LP; Raffaele K; Moser V; Hofstra A; Hoberman A; Makris SL; Garman R; Bolon B; Kaufmann W; Auer R; Lau E; Vidmar T; Bowers WJ
    Neurotoxicol Teratol; 2017 Sep; 63():24-45. PubMed ID: 28757310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A qualitative retrospective analysis of positive control data in developmental neurotoxicity studies.
    Crofton KM; Makris SL; Sette WF; Mendez E; Raffaele KC
    Neurotoxicol Teratol; 2004; 26(3):345-52. PubMed ID: 15113596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposes.
    Fritsche E; Grandjean P; Crofton KM; Aschner M; Goldberg A; Heinonen T; Hessel EVS; Hogberg HT; Bennekou SH; Lein PJ; Leist M; Mundy WR; Paparella M; Piersma AH; Sachana M; Schmuck G; Solecki R; Terron A; Monnet-Tschudi F; Wilks MF; Witters H; Zurich MG; Bal-Price A
    Toxicol Appl Pharmacol; 2018 Sep; 354():3-6. PubMed ID: 29447839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A better approach to in vivo developmental neurotoxicity assessment: Alignment of rodent testing with effects seen in children after neurotoxic exposures.
    Vorhees CV; Sprowles JN; Regan SL; Williams MT
    Toxicol Appl Pharmacol; 2018 Sep; 354():176-190. PubMed ID: 29544898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An industry perspective: A streamlined screening strategy using alternative models for chemical assessment of developmental neurotoxicity.
    Li J; Settivari R; LeBaron MJ; Marty MS
    Neurotoxicology; 2019 Jul; 73():17-30. PubMed ID: 30786249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental toxicology evaluations--issues with including neurotoxicology and immunotoxicology assessments in reproductive toxicology studies.
    Ladics GS; Chapin RE; Hastings KL; Holsapple MP; Makris SL; Sheets LP; Woolhiser MR; Burns-Naas LA
    Toxicol Sci; 2005 Nov; 88(1):24-9. PubMed ID: 16120748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro developmental neurotoxicity (DNT) testing: relevant models and endpoints.
    Bal-Price AK; Hogberg HT; Buzanska L; Lenas P; van Vliet E; Hartung T
    Neurotoxicology; 2010 Sep; 31(5):545-54. PubMed ID: 19969020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotoxicology risk assessment guidelines: developmental neurotoxicology.
    Tilson HA
    Neurotoxicology; 2000; 21(1-2):189-94. PubMed ID: 10794399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward a Better Testing Paradigm for Developmental Neurotoxicity: OECD Efforts and Regulatory Considerations.
    Sachana M; Shafer TJ; Terron A
    Biology (Basel); 2021 Jan; 10(2):. PubMed ID: 33498772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations.
    Dearfield KL; Gollapudi BB; Bemis JC; Benz RD; Douglas GR; Elespuru RK; Johnson GE; Kirkland DJ; LeBaron MJ; Li AP; Marchetti F; Pottenger LH; Rorije E; Tanir JY; Thybaud V; van Benthem J; Yauk CL; Zeiger E; Luijten M
    Environ Mol Mutagen; 2017 Jun; 58(5):264-283. PubMed ID: 27650663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 25th anniversary of the Berlin workshop on developmental toxicology: DevTox database update, challenges in risk assessment of developmental neurotoxicity and alternative methodologies in bone development and growth.
    Marx-Stoelting P; Solano MLM; Aoyama H; Adams RH; Bal-Price A; Buschmann J; Chahoud I; Clark R; Fang T; Fujiwara M; Gelinsky M; Grote K; Horimoto M; Bennekou SH; Kellner R; Kuwagata M; Leist M; Lang A; Li W; Mantovani A; Makris SL; Paumgartten F; Perron M; Sachana M; Schmitt A; Schneider S; Schönfelder G; Schulze F; Shiota K; Solecki R
    Reprod Toxicol; 2021 Mar; 100():155-162. PubMed ID: 33278556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental neurotoxicity testing: scientific approaches towards the next generation to protect the developing nervous system of children. An overview of the Developmental Neurotoxicity Symposium in 2011.
    Aoyama H
    Congenit Anom (Kyoto); 2012 Sep; 52(3):119-21. PubMed ID: 22925211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and molecular neurotoxicology: relevance to biomarker development, neurotoxicity testing and risk assessment.
    Costa LG
    Toxicol Lett; 1998 Dec; 102-103():417-21. PubMed ID: 10022289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral toxicology in the 21st century: challenges and opportunities for behavioral scientists. Summary of a symposium presented at the annual meeting of the neurobehavioral teratology society, June, 2009.
    Bushnell PJ; Kavlock RJ; Crofton KM; Weiss B; Rice DC
    Neurotoxicol Teratol; 2010; 32(3):313-28. PubMed ID: 20171276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential of mechanistic information organised within the AOP framework to increase regulatory uptake of the developmental neurotoxicity (DNT) in vitro battery of assays.
    Sachana M; Willett C; Pistollato F; Bal-Price A
    Reprod Toxicol; 2021 Aug; 103():159-170. PubMed ID: 34147625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Topics in Postnatal Behavioral Testing.
    Henck JW; Elayan I; Vorhees C; Fisher JE; Morford LL
    Int J Toxicol; 2016 Sep; 35(5):499-520. PubMed ID: 27381384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An analysis of the limitations and uncertainties of in vivo developmental neurotoxicity testing and assessment to identify the potential for alternative approaches.
    Paparella M; Bennekou SH; Bal-Price A
    Reprod Toxicol; 2020 Sep; 96():327-336. PubMed ID: 32781019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.